Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Retatrutide is one of the most advanced investigational peptides designed to support weight management, insulin regulation, and metabolic health. Developed as a triple agonist, Retatrutide uniquely activates GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors. This powerful triple action helps promote fat loss, glucose control, and energy balance, making it one of the most promising innovations in the field of metabolic research.
Unlike traditional GLP-1 agonists such as Semaglutide and Tirzepatide, Retatrutide has demonstrated even greater potential for improving weight reduction and metabolic markers. Early clinical research suggests that participants using Retatrutide experience enhanced fat oxidation, reduced appetite, and improved insulin sensitivity — with results that may exceed those of previous generation incretin peptides.
Retatrutide mimics the effects of three key metabolic hormones:
GIP receptor activation improves insulin secretion and sensitivity.
GLP-1 receptor activation reduces appetite, delays gastric emptying, and helps stabilize blood sugar levels.
Glucagon receptor activation promotes increased energy expenditure and fat metabolism.
Together, these pathways target weight loss, metabolic health, and glycaemic balance, positioning Retatrutide as a next-generation peptide for advanced research use.
Supports significant reductions in body weight and body fat
Enhances glucose regulation and insulin response
Promotes increased energy expenditure
Reduces appetite and cravings
Contributes to improved metabolic flexibility
May outperform dual agonists like Tirzepatide in early studies
Brand: ChemAesthetic
Peptide: Retatrutide
Available strengths: 40mg
Form: Lyophilized peptide (powder)
For laboratory and research use only
Each batch of Retatrutide is produced under strict laboratory conditions and undergoes independent third-party lab testing to verify purity, potency, and peptide integrity.
Our Retatrutide formulations are designed for researchers who require verified, high-purity peptides for advanced metabolic and endocrinological studies.
Disclaimer:
This product is sold for laboratory and research use only. It is not intended for human consumption. All information provided is for educational and research purposes.
Retatrutide is one of the most advanced investigational peptides designed to support weight management, insulin regulation, and metabolic health. Developed as a triple agonist, Retatrutide uniquely activates GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors. This powerful triple action helps promote fat loss, glucose control, and energy balance, making it one of the most promising innovations in the field of metabolic research.
Unlike traditional GLP-1 agonists such as Semaglutide and Tirzepatide, Retatrutide has demonstrated even greater potential for improving weight reduction and metabolic markers. Early clinical research suggests that participants using Retatrutide experience enhanced fat oxidation, reduced appetite, and improved insulin sensitivity — with results that may exceed those of previous generation incretin peptides.
Retatrutide mimics the effects of three key metabolic hormones:
GIP receptor activation improves insulin secretion and sensitivity.
GLP-1 receptor activation reduces appetite, delays gastric emptying, and helps stabilize blood sugar levels.
Glucagon receptor activation promotes increased energy expenditure and fat metabolism.
Together, these pathways target weight loss, metabolic health, and glycaemic balance, positioning Retatrutide as a next-generation peptide for advanced research use.
Supports significant reductions in body weight and body fat
Enhances glucose regulation and insulin response
Promotes increased energy expenditure
Reduces appetite and cravings
Contributes to improved metabolic flexibility
May outperform dual agonists like Tirzepatide in early studies
Brand: ChemAesthetic
Peptide: Retatrutide
Available strengths: 40mg
Form: Lyophilized peptide (powder)
For laboratory and research use only
Each batch of Retatrutide is produced under strict laboratory conditions and undergoes independent third-party lab testing to verify purity, potency, and peptide integrity.
Our Retatrutide formulations are designed for researchers who require verified, high-purity peptides for advanced metabolic and endocrinological studies.
Disclaimer:
This product is sold for laboratory and research use only. It is not intended for human consumption. All information provided is for educational and research purposes.
